Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-90
SponsorThe Cleveland Clinic

About this trial

Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.

Eligibility criteria

Qualifiers

History of amblyopia or presence of amblyogenic risk factors.

Disqualifiers

History of neurologic disorders

Trial design

Treatments tested in this trial

  • Patching therapy, Glasses

Treatment groups

150 Participants
are divided into 2 treatment groups

Sponsors and collaborators